Pharmaceutical companies face numerous hurdles during early development, from API manufacturing to drug product formulation to clinical supply logistics. Navigating these hurdles with speed is critical in the race to reach Phase I. One solution to maintaining that speed while mitigating risk is to work with a partner who specializes in numerous facets of drug development within one network.
Join this webinar to hear Thermo Fisher Scientific experts discuss how a simplified supply chain may help increase efficiency and reduce risk as your move to your Phase I milestone. They will also cover the latest enhancements to Thermo Fisher’s Quick to Clinic™ offering for Oral Solids, which now includes API manufacturing and essential solid state chemistry services.